(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Bob Mulroy, CEO of Merrimack Pharmaceuticals, on biotech earnings, consumer health and oncology, and its product pipeline. Broadcasting live from the Boston Convention and Exhibition Center.

Apple Slides Most Since 2025 After Supply Shortages Hurt Outlook
17:44

Instant Reaction: Apple Slides After Supply Shortages Hurt Its Sales Forecast
10:27

Instant Reaction: Amazon Reports Cloud Sales Growth for Fifth Straight Quarter
18:09